Chronic consumers of boiled coffee have elevated serum levels of lipoprotein(a)

Journal of Internal Medicine

Volumn 240, Issue 6, 1996, Pages 367-371

  Urgert, R ^a   Weusten Van Der Wouw, M P M E ^a   Hovenier, R ^a   Lund Larsen, P G ^b   Katan, M B ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b National Health Screening Service   (Norway)

Author keywords

Boiled coffee; Cross sectional study; Lipoprotein(a); Norwegians

Indexed keywords

LIPOPROTEIN A;

ADULT; ARTICLE; COFFEE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; NORWAY; PRIORITY JOURNAL;

EID: 0030477044     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.51885000.x     Document Type: Article

References (30)

1. Dahlén GH. Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 1994; 108: 111-26.
2. Schaefer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Ordovas JM, Davis CE. Lipoprotein(a) levels and risk of coronary heart disease in men. The Lipid Research Clinics Coronary Primary Prevention Trial. JAMA 1994; 271: 999-1003.
3. Terres W, Tatsis E, Pfalzer B, Beil FU, Beisiegel U, Hamm CW. Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a). Circulation 1995; 91: 948-50.
4. Bostom AG, Gagnon DR, Cupples LA, Wilson PWF, Jenner JL, Ordovas JM. A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women - The Framingham Heart Study. Circulation 1994; 90: 1688-95.
5. Cremer P, Nagel D, Labrot B, Mann H, Muche R, Elster H, Seidel D. Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest 1994; 24: 444-53.
6. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992; 90: 52-60.
7. Selby JV, Austin MA, Sandholzer C, Quesenberry CP, Zhang D, Mayer E, Utermann G. Environmental and behavioral influences on plasma lipoprotein(a) concentration in women twins. Rev Med 1994; 23: 345-53.
8. Berglund L. Diet and drug therapy for lipoprotein(a). Curr Opinion Lipidol 1995; 6: 48-56.
9. Nestel P, Noakes M, Belling B, McArthur R, Clifton P, Janus E, Abbey M. Plasma lipoprotein lipid and lp(a) changes with substitution of elaidic acid for oleic acid in the diet. J Lipid Res 1992; 33: 1029-36.
10. Mensink RP, Zock PL, Katan MB, Hornstra G. Effect of dietary cis and trans fatty acids on serum lipoprotein(a) levels in humans. J Lipid Res 1992; 33: 1493-501.
11. Aro A, Teirila J, Gref CG. Dose-dependent effect on serum cholesterol and apoprotein B concentrations by consumption of boiled, non-filtered coffee. Atherosclerosis 1990; 83: 257-61.
12. Bak AAA, Grobbee DE. The effect on serum cholesterol levels of coffee brewed by filtering or boiling. N Engl J Med 1989; 321: 1432-7.
13. Van Dusseldorp M, Katan MB, Van Vliet T, Demacker PNM, Stalenhoef A. Cholesterol-raising factor from boiled coffee does not pass a paper filter. Arterioscler Thromb 1991; 11: 586-93.
14. Bønaa K, Arnesen E, Thelle DS, Førde OH. Coffee and cholesterol: Is it all in the brewing. The Tromsø Study. Brit Med J 1988; 297: 1103-4.
15. Lindahl B, Johansson I, Huhtasaari F, Hallmans G, Asplund K. Coffee drinking and blood cholesterol - effects of brewing method, food intake and life style. J Intern Med 1991; 230: 299-305.
16. Pietinen P, Aro A, Tuomilehto J, Uusitalo U, Korhonen H. Consumption of boiled coffee is correlated with serum cholesterol in Finland. Int J Epidemiol 1990; 19: 586-90.
17. Stensvold I, Tverdal A, Foss OP. The effect of coffee on blood lipids and blood pressure. Results from a Norwegian cross-sectional study, men and women. 40-12 years. J Clin Epidemiol 1989; 42: 877-84.
18. Heckers H, Gobel U, Kleppel U. End of the coffee mystery: diterpene alcohols raise serum low-density lipoprotein cholesterol and triglyceride levels J Intern Med 1994; 235: 192-3.
19. Weusten-van der Wouw MPME, Katan MB, Viani R, Huggett AC, Liardon R, Lund-Larsen PG, et al. Identity of the cholesterol-raising factor from boiled coffee and its effects on liver function enzymes. J. Lipid Res 1994; 35: 721-33.
20. Urgert R, van der Weg G, Kosmeijer-Schuil TG, van de Bovenkamp P, Hovenier R, Katan MB. Levels of the cholesterol-elevating diterpenes cafestol and kahweol in various coffee brews. J Agric Food Chem 1995; 43: 2167-72.
21. Van Rooij J, Van der Stegen GHD, Schoemaker RC, Kroon C, Burggraaf J, Hollaar L, et al. A placebo-controlled parallel study of the effect of two types of coffee oil on serum lipids and transaminases: identification of chemical substances involved in the cholesterol-raising effect of coffee. Am J Clin Nutr 1995; 61: 1277-83.
22. Urgert R, Schulz AGM, Katan MB. Effects of cafestol and kahweol from coffee grounds on serum lipids and serum liver enzymes in humans. Am J Clin Nutr 1995; 61: 149-54.
23. Kraft HG, Menzel HJ, Hoppichler F, Vogel W, Utermann G. Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J Clin Invest 1989; 83: 137-42.
24. Rader DJ, Cain W, Zech LA, Usher D, Brewer HB. Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein(a) isoform is determined by the rate of lipoprotein(a) production. J Clin Invest 1993; 91: 443-7.
25. Nilssen O, Førde OH. Seven-year longitudinal population study of change in gamma-glutamyltransferase : the Tromsø study. Am J Epidemiol 1994; 139: 787-92.
26. White AL, Lanford RE. Biosynthesis and metabolism of lipoprotein(a). Curr Opinion Lipidol 1995; 6: 75-80.
27. Ritter MM, Geiss HC, Richter WO, Schwandt P. Lipoprotein(a) concentrations and phenotypes in controls and patients with hypercholesterolemia or hypertriglyceridemia. Metabolism 1994; 43: 572-8.
28. Gregory WL, Game FL, Farrer M, Idle JR, Laker MF, James OFW. Reduced serum lipoprotein(a) levels in patients with primary biliary cirrhosis. Atherosclerosis 1994; 105: 43-50.
29. Van Wersch JWJ. The behaviour of lipoprotein(a) in patients with various diseases. Scand J Clin Lab Invest 1994; 54: 559-62.
30. Tverdal A, Stensvold. I, Solvoll K, Foss OP, Lund-Larsen P, Bjartveit K. Coffee consumption and death from coronary heart disease in middle aged Norwegian men and women. Brit Med J 1990; 300: 566-569.